The impact of somatic and cognitive depressive symptoms on medical prognosis in patients with end-stage renal disease
Document Type
Journal Article
Publication Title
Perspectives in Psychiatric Care
Volume
58
Issue
1
First Page
297
Last Page
303
PubMed ID
33861469
Publisher
Wiley
School
School of Nursing and Midwifery
RAS ID
35625
Funders
The Deanship of Scientific Research - The University of Jordan
Abstract
Purpose:
To determine whether somatic or cognitive depressive symptoms affect hospitalization and death in patients with end-stage renal disease.
Design and Method:
In an observational retrospective design, the patients (n = 190) completed the Beck Depression Inventory-II at baseline and were followed for 5 years to collect data all-cause mortality and hospitalization.
Findings:
High somatic (53.7%, n = 102) and cognitive (52.1%, n = 99) depressive symptoms scores significantly associated with mortality (38% vs. 19%; hazard ratio [HR] = 2; 95% CI, 1.1–3.7; p = 0.02) and hospitalization (62.5% vs. 49.4%; HR = 1.6; 95% CI, 1.0–2.6; p = 0.03), respectively.
Practice Implications:
In the context of diagnosing and intervening, awareness of depressive symptoms dimensionality is crucial.
DOI
10.1111/ppc.12786
Access Rights
subscription content
Comments
Khalil, A. A., Darawad, M. W., Abed, M. A., Hamdan‐Mansour, A., Arabiat, D. H., Alnajar, M. K., & Saleh, Z. T. (2022). The impact of somatic and cognitive depressive symptoms on medical prognosis in patients with end‐stage renal disease. Perspectives in Psychiatric Care, 58(1), 297-303.
https://doi.org/10.1111/ppc.12786